Extending influenza vaccination to individuals aged 50-64: A budget impact analysis

International Journal of Technology Assessment in Health Care

Volumn 26, Issue 3, 2010, Pages 288-293

  Cicchetti, Americo ^a,b   Ruggeri, Matteo ^a   Gitto, Lara ^c   Mennini, Francesco Saverio ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Basic reproduction number; Economic model; Influenza vaccine

Indexed keywords

BASIC REPRODUCTION NUMBER; BUDGET ALLOCATION; DECISION MAKERS; DYNAMIC EFFECTS; ECONOMIC EVALUATIONS; ECONOMIC MODEL; GERMANY; IMPACT ANALYSIS; INFLUENZA VACCINES; OPTIMAL COVERAGE; PROBABILISTIC SENSITIVITY ANALYSIS; SOCIAL BENEFITS; TRANSMISSION POWER; VIRAL INFECTIONS;

OPTIMIZATION; SENSITIVITY ANALYSIS;

BUDGET CONTROL;

AGE; ARTICLE; BUDGET; CONTROLLED STUDY; DISEASE TRANSMISSION; ECONOMIC EVALUATION; FRANCE; GERMANY; HEALTH CARE COST; INFLUENZA; INFLUENZA VACCINATION; ITALY; SENSITIVITY ANALYSIS; SIMULATION; SPAIN; ECONOMICS; EUROPE; HEALTH CARE DELIVERY; HUMAN; MIDDLE AGED; PREVENTIVE HEALTH SERVICE; STATISTICAL MODEL;

INFLUENZA VACCINE;

BUDGETS; EUROPE; HEALTH SERVICES ACCESSIBILITY; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA VACCINES; MIDDLE AGED; MODELS, ECONOMIC;

EID: 78049441307     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462310000280     Document Type: Article

References (27)

1. Aballéa S, Chancellor J,MartinM, et al. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: An international model. Value Health. 2007;10:98-116.
2. Aballéa S, De Juanes R, Barbieri M. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: A modelbased analysis for Spain. Vaccine. 2007;25:6900-6910.
3. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: A randomised control trial. Lancet. 2000;355:93-97.
4. Centre d'estutis en economia de la salud i de la politica social. Base de datos. Barcellona: SOIKOS; 2004.
5. Chowell G, Nishiura H, Bettencourt LMA. Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. J R Soc Interface. 2006;8:1-12.
6. Eichner M, Schwehm M, Duerr HP, et al. The influenza pandemic preparedness planning tool Influsim. BMC Infect Dis. 2007;13:7-17.
7. European Scientific Working Group on Influenza. The benefits of influenza vaccination. Options for the control of influenza. Crete: ESWI Conference; September 23-28, 2000.
8. http://www.biam2.org. (Accessed March to June 2008)
9. http://davinci.istat.it/daWinci/jsp/MD/dawinciMD.jsp. (Accessed March to June 2008)
10. http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/ Internet/EN/Navigation/Statistics/VerdiensteArbeitskosten/ VerdiensteArbeitskosten.psml. (Accessed March to June 2008)
11. http://www.g-drg.de. (Accessed March to June 2008)
12. http://www.giofil.it. (Accessed March to June 2008)
13. http://www.ined.fr/en/resources-documentation/doc-research/.(Accessed March to June 2008)
14. http://www.ine.es/en/inebmenu/mnu-cifraspob-en.htm. (Accessed March to June 2008)
15. http://www.rote-liste.de/Online. (Accessed March to June 2008)
16. http://www.sante-sports.gouv.fr/etudes-recherchesstatistiques.
17. ISPOR. Country specific pharmacoeconomic guidelines.Dublin: ISPOR; 2006.
18. Jefferson T, Smith S, Demicheli V, et al. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: Systematic review. Lancet. 2005;365:773-780.
19. McElhaney J. Neuraminidase inhibitors in the elderly and highrisK.In: Program and abstracts of the Second International Symposium on Influenza and Other Respiratory Viruses. Grand Cayman Islands, British West Indies; 1999.
20. Medicom SA. Vademecum internacional.Madrid: Medi Medic; 2005.
21. Ministero della Salute. Ricognizione e primo aggiornamento delle tariffe massime per la remunerazione delle prestazioni sanitarie. Roma: Gazzetta Ufficiale dello Stato; 2006.
22. Office for Technology Assessment. Cost-effectiveness of influenza vaccination. Washington, DC: Congress of the United States; 1981.
23. Sistema Nacional de Salud. Estadisticos de referencia estatal de los sistemas de agrupacion de registros de pacientes. Madrid: CMBD; 1999.
24. Turner D, Wailoo A, Nicholson K, et al. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess. 2003;7:1-182.
25. Wallinga J, Teunis P, Kretzschmar M. Using social contact data to estimate age-specific transmission parameters for infectious respiratory spread agents. Am J Epidemiol. 2006;164:936-944.
26. Wezel H. Handkommentar zum EBM mit BMÄ und E-GO und GOÄ. 6 edn 43 Erg̈anzungslieferung: St. Augustin; 1999.
27. World Health Organisation. Influenza vaccines: Recommendations for the use of inactivated influenza vaccines and other preventive measures. Wkly Epidemiol Rec. 2000;75: 281-288.